Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 142.20B | 135.63B | 129.29B | 109.33B | 109.64B | 117.22B |
Gross Profit | 23.64B | 23.01B | 18.79B | 15.53B | 15.77B | 17.63B |
EBITDA | 14.31B | 13.59B | 8.96B | 6.75B | 7.43B | 9.16B |
Net Income | 8.89B | 8.22B | 5.05B | 3.79B | 4.54B | 5.59B |
Balance Sheet | ||||||
Total Assets | 130.13B | 130.84B | 122.12B | 116.08B | 93.10B | 95.42B |
Cash, Cash Equivalents and Short-Term Investments | 14.11B | 22.10B | 11.16B | 9.35B | 9.95B | 10.46B |
Total Debt | 20.47B | 18.56B | 20.24B | 29.89B | 10.01B | 10.62B |
Total Liabilities | 73.19B | 72.95B | 69.95B | 68.21B | 47.57B | 53.21B |
Stockholders Equity | 56.94B | 57.88B | 52.17B | 47.87B | 45.53B | 42.21B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 14.95B | 13.83B | -18.31B | 1.31B | -4.41B |
Operating Cash Flow | 0.00 | 15.95B | 15.94B | -16.71B | 2.60B | -3.68B |
Investing Cash Flow | 0.00 | -807.00M | -1.92B | -1.96B | -1.15B | -675.00M |
Financing Cash Flow | 0.00 | -4.21B | -12.22B | 18.06B | -1.97B | -664.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥83.27B | 10.13 | 5.58% | 4.90% | 62.09% | ||
78 Outperform | ¥76.98B | 13.63 | 1.12% | 17.42% | -12.69% | ||
75 Outperform | ¥71.99B | 19.74 | 0.56% | -12.15% | ― | ||
74 Outperform | ¥138.81B | 16.69 | 7.81% | -7.59% | 18.77% | ||
69 Neutral | ¥106.36B | 16.20 | 3.74% | 2.61% | -9.19% | ||
69 Neutral | ¥93.04B | 16.32 | 2.72% | 10.88% | -29.60% | ||
68 Neutral | £2.94B | 11.91 | 7.23% | 3.38% | 3.00% | -15.12% |